Physician profile
Caitlin Marks
NPI 1932778099
$3,704.19
in general payments reported to CMS, 2019-2025
13 companies · $981 in 2025
The $981 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.16 · 2022: $1,276 · 2023: $752 · 2024: $623 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,355.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,217.09 | 2022-2023 | |
| Integra Lifesciences Corporation | $796.07 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $284.38 | 2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $278.24 | 2024-2025 | Novosorb Btm |
| Kci USA, INC. | $210.65 | 2022-2023 | V.A.C. Veraflo, Prevena, Prevena Restor Bellaform |
| Kerecis Limited | $208.21 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $148.70 | 2023-2025 | Biosurgery - Tisseel |
| Rti Surgical, INC | $142.87 | 2025 | |
| Motiva USA, LLC | $138.05 | 2025 | |
| Tela Bio, INC. | $128.65 | 2024 | Ovitex 2s |
| Solventum Corporation | $96.89 | 2024-2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Regeneron Healthcare Solutions, INC. | $30.46 | 2023 | Libtayo |
| Molnlycke Health Care US, LLC | $23.93 | 2023 | Mlnlyckez-Flo Fluidized Positioner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.